Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MOREFor induction of estrus in prepuberal gilts and healthy weaned sows experiencing delayed return to estrus.
LEARN MORE